Iovance Biotherapeutics Inc (IOVA)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Frederick G. Vogt
Employees:
500
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
6502607120
Date | Ratio |
---|---|
2010-04-06 | 24:1 |
2013-09-26 | 1:100 |
Iovance Biotherapeutics, Inc. focuses on developing and commercializing cancer immunotherapy products. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma. The company was incorporated in 2007 and is headquartered in San Carlos, California.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|